$ABBV Recent News Yet again, Dow, S&P 500 notch new

New Post Public Reply Private Reply Replies (0) Message Board

Jun 22, 2014 at 2:20 PM

$ABBV Recent News

Yet again, Dow, S&P 500 notch new records 4:44 p.m. June 20, 2014 - Victor Reklaitis
Oracle slides on disappointing results; CarMax soars 4:16 p.m. June 20, 2014 - Ben Eisen
Shire boosts FTSE 100 to fourth day in black 12:37 p.m. June 20, 2014 - Sara Sjolin
European stocks lose steam after consumer data 12:09 p.m. June 20, 2014 - Sara Sjolin
AbbVie fails to woo Shire, but investors think someone can do it 11:10 a.m. June 20, 2014 - blogs.marketwatch.com
Newscast: A drug merger is on hold 10:04 a.m. June 20, 2014 - MarketWatch
Stock futures seesaw, but indexes eye weekly gains 8:04 a.m. June 20, 2014 - Carla Mozee
Newscast: A drug merger isn't happening right now 7:39 a.m. June 20, 2014 - MarketWatch
Shire rebuffs $46 billion takeover bid from AbbVie 3:29 a.m. June 20, 2014 - WSJ Staff
Rival to Gilead's pricey Sovaldi expected to hit market later this year 7:28 a.m. June 18, 2014 - blogs.marketwatch.com
E-Trade, Schwab up on HFT hearing; Tesla extends gains 3:53 p.m. June 17, 2014 - Ben Eisen
Microsoft, Amazon, Starbucks are stocks to watch 8:46 a.m. April 25, 2014 - Sue Chang
AbbVie shares rise after earnings top forecasts 8:10 a.m. April 25, 2014 - Ben Eisen
AbbVie shares rise 2.4% premarket on earnings 8:03 a.m. April 25, 2014 - Ben Eisen
Abbvie Q1 EPS tops forecast of $0.68 8:02 a.m. April 25, 2014 - Ben Eisen
AbbVie reaffirms 2014 adj EPS range of $3 to $3.10 8:00 a.m. April 25, 2014 - Ben Eisen
AbbVie Q1 sales rise to $4.56 bln vs $4.33 bln 7:59 a.m. April 25, 2014 - Ben Eisen
AbbVie Q1 EPS edges up to $0.61; Adjusted: $0.71 7:59 a.m. April 25, 2014 - Ben Eisen
AbbVie Q1 profit rises to $980 mln vs $968 mln 7:59 a.m. April 25, 2014 - Ben Eisen
I have no qualms about taking Gilead’s $84,000 drug 7:30 a.m. April 22, 2014 - Tim Mullaney

Dow, S&P 500 End at Records 7:33 p.m. June 20, 2014 - The Wall Street Journal Interactive Edition
Inversion Frenzy Rocks Drug Sector 7:28 p.m. June 20, 2014 - The Wall Street Journal Interactive Edition
Growth Stocks Kick Into Gear In Latest IBD 50 Screen 5:35 p.m. June 20, 2014 - Investors Business Daily
Just a Regular Day of Record Highs, No Big Deal 4:21 p.m. June 20, 2014 - TheStreet.com
European Investors Seek Safety 12:13 p.m. June 20, 2014 - The Wall Street Journal Interactive Edition
Stocks Rise as S&P 500 Extends Record High 12:07 p.m. June 20, 2014 - TheStreet.com
Achillion Could Win Idenix's Mystery Suitor: Analyst 11:44 a.m. June 20, 2014 - Investors Business Daily
Shire Rejects AbbVie's $46 Bil Tax-Inversion Attempt 10:41 a.m. June 20, 2014 - Investors Business Daily
AbbVie Needs More to Land Shire 10:20 a.m. June 20, 2014 - The Wall Street Journal Interactive Edition
AbbVie (ABBV) Is Today's Water-Logged And Getting Wetter Stock 9:52 a.m. June 20, 2014 - TheStreet.com
Shire Rejects $46B AbbVie Offer 9:40 a.m. June 20, 2014 - TheStreet.com
Stock Futures Trade Flat as Iraq Troubles Weigh 8:27 a.m. June 20, 2014 - TheStreet.com
Why Shire (SHPG) Stock Is Soaring This Morning 8:11 a.m. June 20, 2014 - TheStreet.com
AbbVie - Attempt To Acquire Shire Is Driven By Opportunistic Tax Synergies 7:34 a.m. June 20, 2014 - Seeking Alpha
More on AbbVie's pursuit of Shire 7:06 a.m. June 20, 2014 - Seeking Alpha
June 20 Premarket Briefing: 10 Things You Should Know 6:47 a.m. June 20, 2014 - TheStreet.com
European Stocks Lose Momentum but Remain Higher 6:37 a.m. June 20, 2014 - TheStreet.com
Wall Street Breakfast: Ukraine Tensions, Bank Settlements, Siemens Bid 6:33 a.m. June 20, 2014 - Seeking Alpha
Shire rejects AbbVie merger 2:31 a.m. June 20, 2014 - Seeking Alpha
Fire Up The Immuno-Oncology Powerhouses: John McCamant 5:39 p.m. June 19, 2014 - Seeking Alpha

NDA Resubmission, Accelerated Assessment of Marketing Application, and Esteemed Recognition - Analyst Notes on McKesson, AbbVie, Lilly, Zoetis and Salix 5:00 a.m. June 20, 2014 - PR Newswire - PRF
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 11:48 p.m. June 19, 2014 - PR Newswire - PRF
AbbVie Declares Quarterly Dividend 11:28 a.m. June 19, 2014 - PR Newswire - PRF
European Medicines Agency Validates Marketing Authorization Applications for AbbVie's Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 1 Chronic Hepatitis C 2:00 a.m. June 17, 2014 - PR Newswire - PRF
Biogen Idec and AbbVie Announce Positive Top-Line Results from Phase 3 Study Investigating Daclizumab High-Yield Process in Multiple Sclerosis 7:30 a.m. June 16, 2014 - BusinessWire - BZX
U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 1 Chronic Hepatitis C 3:34 p.m. June 13, 2014 - PR Newswire - PRF
Equity Coverage on Pharma Industry -- Research on AbbVie, AcelRx Pharma, Bristol-Myers Squibb, and GW Pharma 7:10 a.m. June 13, 2014 - PR Newswire - PRF
Expansions, New Leadership, Annual Award Winners, FDA Approvals, and Abstracts Presentations - Analyst Notes on AbbVie, Amgen, Regeneron Pharmaceuticals Inc, Valeant Pharmaceuticals and Lilly 6:40 a.m. June 12, 2014 - PR Newswire - PRF
AbbVie Presents Results from Large Global Study of Patient Attitudes and Adherence Across Six Chronic Inflammatory Diseases 2:00 a.m. June 11, 2014 - PR Newswire - PRF
AbbVie to Present at Goldman Sachs 35th Annual Global Healthcare Conference 8:00 a.m. June 10, 2014 - PR Newswire - PRF
AbbVie to Present at Jefferies 2014 Global Healthcare Conference 8:30 a.m. June 3, 2014 - PR Newswire - PRF
AbbVie Presents New Results from Studies of Investigational Oncology Compound ABT-199/GDC-0199 at the 2014 American Society of Clinical Oncology Annual Meeting 8:00 a.m. May 31, 2014 - PR Newswire - PRF
AbbVie Presents Results from Study of Investigational Compound in Patients with Glioblastoma at the American Society of Clinical Oncology's 50th Annual Meeting 8:00 a.m. May 30, 2014 - PR Newswire - PRF
Secondary Offering, Appointments, and Clinical Developments - Analyst Notes on HCA, Biogen Idec, WellPoint, AbbVie and Mylan 7:00 a.m. May 23, 2014 - PR Newswire - PRF
Study Results, Extension of Supply Agreements, Drug Designations, Senior Level Appointments, and Upcoming Events - Analyst Notes on InterMune, Actavis, Bristol-Myers, AbbVie and Illumina 8:30 a.m. May 22, 2014 - PR Newswire - PRF
Morning Analysis on Active Equities -- Research on AbbVie, Johnson Controls, DISH, and CEMEX 8:50 a.m. May 20, 2014 - PR Newswire - PRF
AbbVie to Present at 2014 UBS Global Healthcare Conference 8:00 a.m. May 20, 2014 - PR Newswire - PRF
AbbVie Announces Michael Severino, M.D. to Lead R&D Organization and Drive Continued Pipeline Advancement 12:00 p.m. May 15, 2014 - PR Newswire - PRF
Marketing Authorization Applications, Clinical Trial Results, Awards & Recognitions, and Resources Expansions - Analyst Notes on AbbVie, Medtronic, Abbott, Zimmer and Arena 8:40 a.m. May 15, 2014 - PR Newswire - PRF
Agreements, Earnings Releases, Senior-Level Retirements and Appointments, and Marketing Authorizations - Analyst Notes on Actavis, Jazz Pharmaceuticals, Bristol-Myers, Biogen Idec and AbbVie 7:00 a.m. May 14, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JumpCloud Tackles Compliance in the AI Era

By Kelly Martin Updated Oct 28, 2026 Category News Views 131

Compliance in a Changing Tech Landscape JumpCloud's stepping up in this brave new world riddled with tech and AI agents. They've got fresh platform features in their arsenal that'll keep organizations audit-ready day in and day out. Now, if you think compliance is just for the accountants to fret over, think again. In the agentic era, these advanced marvels—AI agents...

Study Reveals Stark Disparities in Education Equity

Are We Dropping the Ball on Future Talent? Listen, there’s a harsh truth screaming at us from the NWEA’s latest study, and it’s not pretty. We’re talking about a serious gap here, folks—one that shows lower-income kids are getting the short end of the stick in education yet again. When more than half of U.S. students come from lower-income families but only 20%...

2026 Global Ocean Forum Unveils Key Marine Strategies

Riding the Waves in Qingdao It ain't every day that a talk-fest dedicated to oceans gets my attention, but when the Global Ocean Development Forum plants its flag in Qingdao, even I sit up. We're talking about some real fireworks in the marine economy sector with this gig's '1+1+4+8' framework. Now, before you scratch your head on the bingo numbers—it's the opening...

Quad Sees Marginal Gains Amid Industry Challenges

Treading Water with a Splash of Strategic Moves When you're in the thick of market shifts, sometimes it's not about big leaps but staying afloat with purpose. That's what Quad's recent financial release seems to hint at. A steady net sales figure hovering at $587 million for Q3 2026, barely a nudge compared to last year's numbers, sets the tone. It's not the fireworks...

Federal Signal Acquires GVS, Boosts Vacuum Truck Lineup

Federal Signal's Latest Move in Vacuum Truck Arena A shakeup in the vacuum truck market? You bet. Federal Signal Corporation has made waves yet again by acquiring the lion's share of Global Vacuum Systems (GVS) assets and operations. We're talking a transaction valued at a hefty $29 million. Dishing Out the Dollars and Cents Now, what stirs the pot in this deal is the...

Personalized Senior Living Guidance Finds Home in South Jersey

Shaunique Adams and Her Mission in South Jersey In a world where compassion sometimes feels like it's on short supply, Shaunique Adams is making sure it's at the forefront of her mission. Having experienced the emotional whirlwind of caregiving firsthand, Adams has transformed her personal journey into a mission to serve families navigating similar paths. Through Trua...

Civitas Boosts Orlando Luxury Hotel with $386M Loan

Orlando Sets the Stage for Luxury Expansion Well, it seems Orlando's hospitality scene is about to get a significant bump. Civitas Capital Group just tossed a cool $386 million into the pot for the construction of a 700-key luxury hotel on the infamous International Drive. We're not talking about just another hotel here; this one's a real beast, a future InterContinental...

Nikon Unveils Game-Changing Zoom Lens for Pros

Nikon Raises the Bar with New Pro Zoom Lens Well, Nikon's done it again, folks. They've dropped the NIKKOR Z 120-300mm f/2.8 TC VR S lens, and it looks like they're giving photographers something to drool over. Now, before you start rolling your eyes, this isn't just another shiny gadget. This bad boy is lighter and faster than anything Nikon's thrown at us before, and it...

E. Coli Outbreaks Spark Push for New Petting Zoo Laws

A Long-Standing Question Finally Answered There comes a time when asking the same question repeatedly feels like chasing your own tail. That's where Bill Marler, food safety attorney extraordinaire, found himself after two decades of wondering if petting zoos should face the chopping block. Right on the heels of E. coli investigations across Illinois, California, and...

Savvas Launches Miller & Levine Biology Program Revamp

Education Meets Innovation: Savvas Takes a Bold Step Who would have thought biology education could get a makeover that might actually stick? Savvas Learning Company thinks it's onto something with the launch of the all-new Miller & Levine Experience Biology Program. The spotlight's on innovation—it's about time someone shook up the way high schoolers learn biology. A...